Health Disparities in the Development, Persistence, and Progression of Uveitis and Ocular Inflammation in the United States

Information

  • Research Project
  • 10284539
  • ApplicationId
    10284539
  • Core Project Number
    K23EY032985
  • Full Project Number
    1K23EY032985-01
  • Serial Number
    032985
  • FOA Number
    PA-20-205
  • Sub Project Id
  • Project Start Date
    9/30/2021 - 2 years ago
  • Project End Date
    8/31/2026 - 2 years from now
  • Program Officer Name
    AGARWAL, NEERAJ
  • Budget Start Date
    9/30/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/17/2021 - 2 years ago

Health Disparities in the Development, Persistence, and Progression of Uveitis and Ocular Inflammation in the United States

PROJECT SUMMARY Uveitis is an important cause of visual morbidity, responsible for an estimated 10% of blindness in the United States with an annual associated cost of $242.6 million. Prior studies have sought to elucidate the incidence and prevalence of uveitis; however, these studies have been limited in scope by age subset, localized geography, referral practice setting, or specialized health systems environment. The primary objectives of this K23 career development proposal are: 1) to demonstrate the benefit of using multiple databases to characterize the epidemiology of uveitis across the U.S., elucidating disparities in risk factors for its development, persistence, and progression; and 2) to provide an academic uveitis and vitreoretinal surgeon with the training and mentored research experience necessary to conduct independent clinical research. Achieving these objectives will provide critical skills and experiences necessary to establish an independent research program focused on applying clinical informatics to improve the clinical care of patients with uveitis. The proposed K23 application will provide additional training in four vital areas: 1) epidemiology and mechanisms of chronic disease; 2) quantitative characterization of health economics and health disparities; 3) biostatistical methods for health services research; 4) validation and analysis of very large clinical databases. The proposed research will capitalize on the strengths of two unique databases containing large and diverse cohorts of patients, including health claims-based data from the Optum Clinformatics Data Mart and electronic medical record-derived data from the Los Angeles County Department of Health Services safety net healthcare system, to generate exploratory knowledge on health disparities in the epidemiology and treatment of ocular inflammatory diseases. After validating longitudinal samples of patients with uveitis, the prevalence of uveitis in diverse populations will be estimated, documenting race-ethnic and other disparities. Risk factors for the development of uveitis and its sequelae will be incorporated in developing and testing models to investigate to what degree risk factors might affect health disparities. The interaction between race and smoking status will be a particular factor of interest. Population-based treatment patterns and health care costs associated with non-infectious uveitis will be characterized. Socioeconomic disparities in the utilization of steroid-sparing immunomodulatory therapy will be explored. The results of the proposed research will provide the foundation for a future longitudinal study examining the benefit of targeted interventions in patients at higher risk of blindness from uveitis. The ultimate goal of my research is to develop risk-stratification and treatment protocols that guide the standardized care of patients with uveitis and decrease the incidence of ocular inflammatory disease and its associated ocular morbidity.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    K23
  • Administering IC
    EY
  • Application Type
    1
  • Direct Cost Amount
    151864
  • Indirect Cost Amount
    12149
  • Total Cost
    164013
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    867
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NEI:164013\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZEY1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF SOUTHERN CALIFORNIA
  • Organization Department
    OPHTHALMOLOGY
  • Organization DUNS
    072933393
  • Organization City
    Los Angeles
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    900890701
  • Organization District
    UNITED STATES